chapter5a. crd 15march2012 final
TRANSCRIPT
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 1/46
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 2/46
By
H.M. Edi Armanto and Swaditya Rizki Faculty of Agrotechnology and Food Science, UMT - Malaysia
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 3/46
1) Experimental Classification2) Assumptions3) CRD (2 Slides)
4) Field Layout (4 Slides)5) The Linear Model6) Hypothesis7) One-Way-ANOVA (3 Slides)8) Post Hoc Test9) Example 1: Diet Medicines10) Example 2: Pesticide Formulas
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 4/46
Single Factor Experiment
(One way ANOVA):
1) Completely Randomized
Design (CRD)
2) Randomized Complete
Block Design (RCBD)
3) Latin Square Design (LS)
Two or More Factor Experiment
(Two ways ANOVA):
1) Factorial Experiment in CRD
2) Factorial Experiment in RCBD3) Factorial Experiment in LS
4) Split Plot Design (SPD)
5) Strip Block Design (SBD)
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 5/46
1. Randomness & Independence of Errors
• Independent random samples are drawn for each
condition2. Normality
• Populations (for each condition) are Normally Distributed
3. Homogeneity of Variance• Populations (for each condition) have equal variances
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 6/46
1) Experimental Units (object) are assigned randomly totreatments (subjects are assumed homogeneous)
2) Experimental units receive the same treatment
3) One factor of treatment (2 or more treatment levels )4) Analyzed by One-Way ANOVA
5) Appropriate for homogenous experimental unit, i.e.laboratory and not suitable in the Agricultural fields
6) Environmental effects are relatively easy to control
7) It is assumed that there is no interaction
CRD (1)
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 7/46
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 8/46
Treatment Replications1 2 3 4
Experimental units are randomly assigned
to treatments
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 9/46
The Linier Model
i = 1,2,…, t j = 1,2,…, r
X ij = the observation in i th
treatment and the j th
replication
= overall mean
t i
= the effect of the i th
treatment ij = random error
Xij =μ + ti +εij
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 10/46
H0: 1 = 2 = 3 = ... = t
• All Population Means are Equal
• No Treatment Effect
H1: Not All i Are Equal• At Least 1 Pop. Mean is Different
• Treatment Effect
NOT 1 2 ... t
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 11/46
H0: 1 = 2 = 3 = ... = t
• All Population Means are
Equal
• No Treatment Effect
H1 : Not All i Are Equal
• At Least 1 Pop. Mean is
Different
• Treatment Effect
NOT 1 2 ... t
X
f(X)
1 = 2 = 3
X
f(X)
1 = 2 3
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 12/46
1. Compares 2 Types of Variation to Test
Equality of Means
2. Comparison Basis Is Ratio of Variances3. If Treatment Variation Is Significantly Greater
Than Random Variation, then Means Are Not
Equal4. Variation Measures Are Obtained by
‘Partitioning’ Total Variation
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 13/46
Sum of Squares Within Sum of Squares Error
(SSE)
Within Groups Variation
Sum of Squares Among Sum of Squares Between
Sum of SquaresTreatment (SST)
Among Groups Variation
Variation due to
treatment
Variation due to
random sampling
Total variation
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 14/46
The One-Way ANOVA procedure produces
a one-way analysis of variance for a
quantitative dependent variable by a single
factor (independent) variable. Analysis of
variance is used to test the hypothesis that
several means are equal. This technique is
an extension of the two-sample t test.
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 15/46
In addition to determining that differences exist
among the means, you may want to know which
means differ. There are two types of tests for
comparing means: a priori contrasts and post-hoc tests. Contrasts are tests set up before
running the experiment, and pos t hoc tests are
run after the experiment has been conducted.
You can also test for trends across categories.
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 16/46
Once you have determined that differences exist
among the means, post hoc range tests and
pairwise multiple comparisons can determine
which means differ. Range tests identifyhomogeneous subsets of means that are not
different from each other. Pairwise multiple
comparisons test the difference between each
pair of means and yield a matrix where asterisksindicate significantly different group means at an
alpha level of 0.05.
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 17/46
Bonferroni. Uses t tests to perform pairwise
comparisons between group means, but controls
overall error rate by setting the error rate for
each test to the experiment wise error ratedivided by the total number of tests. Hence, the
observed significance level is adjusted for the
fact that multiple comparisons are being made.
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 18/46
Tukey. Uses the Studentized range statistic to make all of
the pairwise comparisons between groups. Sets the
experimentwise error rate at the error rate for the collection
for all pairwise comparisons. Duncan. Makes pairwise comparisons using a stepwise
order of comparisons identical to the order used by the
Student-Newman-Keuls test, but sets a protection level for
the error rate for the collection of tests, rather than an error rate for individual tests. Uses the Studentized range statistic.
And many more…
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 19/46
Three diet medicines (one is commonly used)were tested with 6 replications on the rats. Wewanted to find out which one can be delivered tothe market (the best one according to statistical
analysis). The measured variable is weight lossafter 30-days treatments.
Replications Rat + Treatment
Medicine 1
Rat + Treatment
Medicine 2
Rat + no Medicine
(Used a Control)
1 24 10 7
2 26 12 5
3 11 5 13
4 14 9 10
5 21 17 21
6 17 22 23
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 20/46
Treatments of Diet Medicine (M)Rat+Med 1 Rat+Med 2 Rat+ no Med
Experimental units will be randomly assigned to
treatments by using lottery or other methods
Replications
(6 times)
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 21/46
Note: M: Treatment (Diet Medicine, M1, M2, M3)
R : Rat (Replication, R1, R2, R3, R4, R5,
R6)
Replication
(6 times)
Layout of Experimental Unit for fieldobservations
M1R1
M2R6
M3R2
M2R1
M1R3
M3R4
M2R2
M3R5
M3R3
M2R4
M1R3
M13R6
M1R5
M3R6
M3R1
M1R2
M2R3
M2R5
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 22/46
ReplicationMedicine
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 23/46
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 24/46
1. Determine the data above is normally
distributed and homogeneous.
2. Analyze using one-way ANOVA.
3. Make hypothesis to get a decision
We consider that the data is normally
distributed and homogeneous.
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 25/46
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 26/46
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 27/46
Homogeneous because
0.772 > 050.
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 28/46
050. Significance correction
If the significance obtained > , so the
variance of each sample is homogeneous.
If the significance obtained < , so the
variance of each sample is not homogeneous.
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 29/46
Note: Between Group = Treatments
Within Groups = Error
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 30/46
H0: μ1 = μ2 = μ3
H1: μi not all equal. (i=1,2,3)
Significance correction 050.
If the significance obtained > 0.05 , H0 is received
If the significance obtained < 0.05, H0 is rejected
Conclusion : because of the sig is 0.210, thatmeanssig > 0.05. So all of the medicines have the sameeffect. There is no difference among the medicines.
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 31/46
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 32/46
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 33/46
From the Post Hoc table is obtained that
all of the sig (table) have values more than
0.05 (significance correction). that means,
all of the medicines don’t have differentmean significantly.
Mean difference of medicine 1 2, 13
, 21, 23, 31, 32. All of the meandifference is not significantly.
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 34/46
We can analyze
using Benferroni,
sidak, scheffle,
duncan test, etc likethe Post Hoc box
below, with the
same analysis fromTukey Test.
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 35/46
Three same formulas of pesticides (made in UKM, UPM, UMT). TheUKM pesticide was already standardized (as control). We compare
effectivity of pesticide to kill insects in the 6 experimental stations with
the same doses. The measured variable was amount of killed insects in
the fields. The experimental results are presented in the Table.
Replications UKM (control) UPM UMT
A 50 120 140
B 30 70 125
C 12 70 80D 30 65 90
E 12 90 70
F 30 70 80
G 20 70 80
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 36/46
PesticidesUKM UPM UMT
Experimental units will be randomly assigned to
treatments by using lottery or other methods
Replications(7 times)
A
B
C
D
E
F
G
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 37/46
PesticidesUKM UPM UMT
Replications(7 times)
Note: P: Pesticide (P1: UKM, P2: UPM: P3: UMT)A, B, C, D, E, F, G : Replications
P1A
P2F
P3B
P2A
P1C
P3D
P3G
P2B
P3E
P3C
P2D
P1D
P1F
P1E
P3F
P3A
P1B
P2C
P3E
P2G P1G
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 38/46
Value University
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 39/46
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 40/46
For Post Hoc and Options button is the same like example 1
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 41/46
Note: Between Group = Treatments
Within Groups = Error
Homogeneous because
0.178 > 050.
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 42/46
050. Significance correction
If the significance obtained > , so the
variance of each sample is homogeneous.
If the significance obtained < , so the
variance of each sample is not homogeneous.
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 43/46
H0: μ1 = μ2 = μ3 H1: μi not all equal. (i=1,2,3)
Significance correction 050.
If the significance obtained > 0.05 , H0 is received
If the significance obtained < 0.05, H0 is rejected
Conclusion : because of the sig is 0.000, that
meanssig < 0.05. So H0 is rejected, in other word, H1 isreceived,at least, there is pesticide which is different with other.
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 44/46
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 45/46
1) From the Post Hoc table obtained, for sig value is0.000 (sig < 0.05), that means: two pesticides havethe different impacts. UKM-UPM and UKM-UMT aresignificantly different, that pesticides (made in UPM and
UMT) are better than UKM pesticide. Their causes arethat both pesticides have better active components inthe pesticides.
2) There are sig = 0.348 (sig >0.05). That means: the
two pesticides have the same results, i.e. between UPM – UMT or UMT-UPM have the same capability. Bothpesticides have the same ability to kill insects.
7/28/2019 Chapter5a. CRD 15March2012 Final
http://slidepdf.com/reader/full/chapter5a-crd-15march2012-final 46/46
Many thanks for your attention See you in other occasions